Dillon & Associates Inc Merck & Co., Inc. Transaction History

Dillon & Associates Inc

$721 Million
Q4 2024

A detailed history of Dillon & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dillon & Associates Inc holds 3,040 shares of MRK stock, worth $260,436. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,040

Previous 3,521 13.66%

Holding current value

$260,436

Previous $401,000 24.94%

% of portfolio

0.04%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$96.31 - $114.76 $46,325 - $55,199	-481 Reduced 13.66%	3,040 $301,000
Q3 2024 Nov 05, 2024	BUY	$111.15 - $128.97 $7,780 - $9,027	70 Added 2.03%	3,521 $401,000
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $9,285 - $9,972	75 Added 2.22%	3,451 $428,000
Q1 2024 Apr 30, 2024	SELL	$113.24 - $131.95 $8,493 - $9,896	-75 Reduced 2.17%	3,376 $446,000
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $14,526 - $15,807	-145 Reduced 4.03%	3,451 $376,000
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $7,515 - $8,346	73 Added 2.07%	3,596 $370,000
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $170,159 - $189,863	-1,653 Reduced 31.94%	3,523 $373,000
Q1 2023 May 01, 2023	BUY	$102.94 - $114.86 $181,483 - $202,498	1,763 Added 51.66%	5,176 $550,000
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $437 - $560	-5 Reduced 0.15%	3,413 $379,000
Q2 2022 Jul 26, 2022	SELL	$83.49 - $94.64 $22,959 - $26,026	-275 Reduced 7.45%	3,418 $311,000
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $109,015 - $122,199	-1,483 Reduced 28.65%	3,693 $303,000
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $136,970 - $171,573	-1,895 Reduced 26.8%	5,176 $399,000
Q3 2021 Oct 28, 2021	SELL	$71.68 - $78.83 $343,490 - $377,753	-4,792 Reduced 40.39%	7,071 $530,000
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $113,550 - $125,598	-1,615 Reduced 11.98%	11,863 $925,000
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $18,936 - $22,305	-275 Reduced 2.0%	13,478 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $100,765 - $111,828	1,404 Added 11.37%	13,753 $1.13 Million
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $44,200 - $50,101	604 Added 5.14%	12,349 $1.03 Million
Q2 2020 Jul 28, 2020	BUY	$70.42 - $80.13 $138,375 - $157,455	1,965 Added 20.09%	11,745 $904,000
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $101,059 - $140,072	1,595 Added 19.49%	9,780 $753,000
Q4 2019 Feb 03, 2020	BUY	$77.58 - $87.54 $392,166 - $442,514	5,055 Added 161.5%	8,185 $745,000
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $180,569 - $212,339	3,130 New	3,130 $222,000
Q4 2017 Feb 08, 2018	SELL	$51.62 - $61.64 $161,570 - $192,933	-3,130 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	3,130	3,130 $200,000

Others Institutions Holding MRK

# of Institutions

3,905

Shares Held

1.94B

Call Options Held

15.6M

Put Options Held

13.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $217B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Account

Dillon & Associates Inc Merck & Co., Inc. Transaction History